Condensed Consolidated Interim Financial Statements as of September 30, 2018

Bayer Group
Consolidated Statements of Comprehensive Income

 

 

Q3 2017

 

Q3 2018

 

9M 2017

 

9M 2018

 

 

€ million

 

€ million

 

€ million

 

€ million

1

Total income and expense items (including reclassifcations) that may not or must not be recognized through profit or loss according to other IFRS

Income after income taxes

 

4,196

 

2,894

 

7,944

 

5,653

of which attributable to noncontrolling interest

 

315

 

8

 

756

 

14

of which attributable to Bayer AG stockholders

 

3,881

 

2,886

 

7,188

 

5,639

Remeasurements of the net defined benefit liability for post-employment benefit plans

 

437

 

387

 

1,342

 

293

Income taxes

 

(80)

 

(117)

 

(407)

 

(59)

Other comprehensive income from remeasurements of the net defined benefit liability for post-employment benefit plans

 

357

 

270

 

935

 

234

Changes in fair values of own credit risk component of financial liabilities measured at fair value

 

 

(6)

 

 

(6)

Income taxes

 

 

2

 

 

2

Other comprehensive income from financial liabilities measured at fair value through profit or loss

 

 

(4)

 

 

(4)

Changes in fair values of equity instruments measured at fair value

 

 

(60)

 

 

125

Income taxes

 

 

3

 

 

1

Other comprehensive income from equity instruments measured at fair value

 

 

(57)

 

 

126

Other comprehensive income relating to associates accounted for using the equity method

 

 

 

 

4

Other comprehensive income that will not be reclassified subsequently to profit or loss

 

357

 

209

 

935

 

360

Changes in fair values of cash flow hedges

 

20

 

(111)

 

(58)

 

204

Reclassified to profit or loss

 

(25)

 

76

 

2

 

19

Income taxes

 

10

 

(11)

 

33

 

(94)

Other comprehensive income from cash flow hedges

 

5

 

(46)

 

(23)

 

129

Changes in fair values of available-for-sale financial assets

 

12

 

 

(22)

 

Reclassified to profit or loss

 

(4)

 

 

(4)

 

Income taxes

 

 

 

8

 

Other comprehensive income from available-for-sale financial assets

 

8

 

 

(18)

 

Changes in exchange differences recognized on translation of operations outside the eurozone

 

(523)

 

(119)

 

(1,907)

 

520

Reclassified to profit or loss

 

 

160

 

 

160

Other comprehensive income from exchange differences

 

(523)

 

41

 

(1,907)

 

680

Other comprehensive income relating to associates accounted for using the equity method

 

45

 

(1)

 

92

 

1

Other comprehensive income that may be reclassified subsequently to profit or loss

 

(465)

 

(6)

 

(1,856)

 

810

Total other comprehensive income1

 

(108)

 

203

 

(921)

 

1,170

of which attributable to noncontrolling interest

 

(43)

 

(12)

 

(106)

 

(17)

of which attributable to Bayer AG stockholders

 

(65)

 

215

 

(815)

 

1,187

Total comprehensive income

 

4,088

 

3,097

 

7,023

 

6,823

of which attributable to noncontrolling interest

 

272

 

(4)

 

650

 

(3)

of which attributable to Bayer AG stockholders

 

3,816

 

3,101

 

6,373

 

6,826

Compare to Last Year